Category: Healthcare

Press Release Nov 9, 2015
ASI vereinbart Partnerschaft mit ScreenCell zur Entwicklung eines neuartigen, nicht-invasiven pränatalen Diagnoseverfahrens auf Grundlage zirkulierender fetaler Zellen

Kooperation zur Behebung der NIPT-Beschränkungen und Erweiterung des Spektrums an diagnostizierbaren Anomalien.
Press Release Nov 4, 2015
Riassunto: ASI e ScreenCell si alleano per sviluppare un sistema di diagnosi prenatale non invasivo basato sulle cellule fetali in circolazione

Obiettivo è risolvere i limiti dei test prenatali non invasivi ed espandere la gamma delle anomalie diagnosticabili
Press Release Nov 4, 2015
Resumen: ASI Partners y ScreenCell desarrollarán un nuevo diagnóstico prenatal no invasivo basado en las células fetales de la circulación

Se busca resolver las limitaciones de las pruebas prenatales no invasivas y ampliar el rango de diagnóstico de las anomalías
Press Release Nov 4, 2015
ASI Partners with ScreenCell to Develop a Novel, Non-Invasive Prenatal Diagnosis Based on Circulating Fetal Cells

Seek to resolve NIPT limitations, expand range of diagnosable abnormalities.
Press Release Apr 16, 2015
Applied Spectral Imaging Received South Korean Ministry of Food and Drug Safety (MFDS) Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67